Shelly Fowler, PA
Physician Assistant · Leeds, MANPI 1598954208
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.7% of the total across 384 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 22.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $2,889 and has fallen 58.4% since, to $1,202 in 2025. Among physician assistant clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 384 payments — averaging $20.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Regeneron Healthcare Solutions, Inc.$1K
- GSK$1K
- Pfizer$662
- Sanofi$622
- Amgen$618
- plus $1K from 19 others
What the payments were for
- Food & beverage$7,73998%
- Education$1812%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 79 | $1,759 |
| Regeneron Healthcare Solutions, Inc. | 69 | $1,419 |
| GSK | 79 | $1,365 |
| Pfizer | 32 | $662 |
| Sanofi | 25 | $622 |
| Amgen | 24 | $618 |
| LEO Pharma Inc. | 13 | $210 |
| Biocryst US Sales Co., LLC | 15 | $203 |
| CSL Behring | 8 | $179 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $160 |
| Boehringer Ingelheim | 8 | $149 |
| Blueprint Medicines Corporation | 4 | $106 |
| AbbVie | 1 | $79 |
| Pharming Healthcare, Inc. | 3 | $64 |
| Aimmune Therapeutics, Inc. | 3 | $58 |
| GC Biopharma USA, Inc. | 2 | $49 |
| Novartis | 3 | $46 |
| Genentech USA, Inc. | 2 | $32 |
| Kedrion Biopharma, Inc. | 1 | $24 |
| Bio Products Laboratory USA, Inc. | 1 | $22 |
| Covis Pharma GmbH | 1 | $21 |
| Sanofi US Services Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $18 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $18 |
| Kaleo, Inc. | 1 | $16 |
How this compares
$7,919 in reported general payments places this provider in the 95th percentile of 3,507 physician assistant providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 11 | $45,339 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 17 | $10,616 |
| Breo ElliptaFluticasone/Vilanterol | 20 | $10,415 |
| AirsupraAlbuterol Sulfate/Budesonide | 15 | $7,045 |
| Epinephrine | 21 | $4,652 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 16 | $1,620 |
| Ventolin HfaAlbuterol Sulfate | 12 | $699 |
| Betamethasone Dipropionate | 18 | $686 |
| Azelastine Hcl | 31 | $613 |
| Ipratropium Bromide | 18 | $445 |
| Fluticasone Propionate | 24 | $406 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 15 | $381 |
| Triamcinolone Acetonide | 17 | $111 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaBreztri Aerosphere, Airsupra | $1,759 | $17,66132 claims |
| GSKBreo Ellipta | $1,365 | $10,41520 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,507 physician assistant providers in Massachusetts.
Other physician assistant in Leeds
- Christopher MasseyWilbraham$190K
- Lizabeth O ConnorEverett$182K
- Kimberly ComeauSwampscott$120K
- Stacey PanasciSpringfield$113K
- Jason RandWaltham$99K
- Karen ChunEast Boston$70K
- David PeckhamQuincy$61K
- Leslie SmithSpringfield$49K
- Andrea MilliganBoston$46K
- Lauren RousseauBoston$42K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.